1 Xu J，Liu L，Wang Y，et al. TOAST subtypes：its

influence upon doctors' decisions of antihypertensive

prescr ipt ion at discharge for ischemic st roke

patients[J]. Patient Prefer Adherence，2012，6：911-

914.

2 Wang Y，Zhao X，Liu L，et al. Prevalence and

outcomes of symptomatic intracranial large artery

stenoses and occlusions in China：the Chinese

Intracranial Atherosclerosis (CICAS) Study[J]. Stroke，

2014，45：663-669.

3 董强，黄家星，黄一宁，等. 症状性动脉粥样硬化性颅

内动脉狭窄中国专家共识[J]. 中华神经精神疾病杂志，

2012，38：129-145.

170 Chin J Stroke, Feb 2017, Vol 12, No.2

17 Gao S，Wang YJ，Xu AD，et al. Chinese ischemic

stroke subclassification[J]. Front Neurol，2011，2：6.

18 Rosenf ield K，Matsumura JS，Chaturvedi S，et

al. Randomized Trial of Stent versus Surgery for

Asymptomatic Carotid Stenosis[J]. N Engl J Med，

2016，374：1011-1020.

19 Warfarin-Aspirin Symptomatic Intracranial Disease

(WASID) Trial Investigators. Design，progress

and challenges of a double-blind trial of warfarin

versus aspirin for symptomatic intracranial arterial

stenosis[J]. Neuroepidemiology，2003，22：106-117.

20 Chimowitz MI，Lynn MJ，Turan TN，et al. Design of

the stenting and aggressive medical management for

preventing recurrent stroke in intracranial stenosis

trial[J]. J Stroke Cerebrovasc Dis，2011，20：357-368.

21 Brinjikji W，Huston J 3rd，Rabinstein AA，et al.

Contemporary carotid imaging：from degree of

stenosis to plaque vulnerability[J]. J Neurosurg，2016，

124：27-42.

22 Naghavi M，Libby P，Falk E，et al. From vulnerable

plaque to vulnerable patient：a call for new definitions

and risk assessment strategies：Part Ⅱ[J]. Circulation，

2003，108：1772-1778.

23 Muller JE，Stone PH，Turi ZG，et al. Circadian

variation in the frequency of onset of acute myocardial

infarction[J]. N Engl J Med，1985，313：1315-1322.

24 Ha SM，Suh SI，Seo WK，et al. Arterial wall imaging

in symptomatic carotid stenosis：delayed enhancement

on MDCT angiography[J]. Neurointervention，2016，

11：18-23.

25 Millon A，Mathevet JL，Boussel L，et al. Highresolution

magnetic resonance imaging of carotid

atherosclerosis identifies vulnerable carotid plaques[J].

J Vasc Surg，2013，57：1046-1051. e2.

26 Si n g h N，Moody AR，Glad s tone DJ，e t a l .

Moderate carotid artery stenosis：MR imagingdepicted

intraplaque hemorrhage predicts risk of

cerebrovascular ischemic events in asymptomatic

men[J]. Radiology，2009，252：502-508.

27 Klein IF，Lavallée PC，Mazighi M，et al. Basilar

artery atherosclerotic plaques in paramedian and

lacunar pontine infarctions：a high-resolution MRI

study[J]. Stroke，2010，41：1405-1409.

28 Klein IF，Lavallée PC，Touboul PJ，et al. In vivo

middle cerebral artery plaque imaging by highresolution

MRI[J]. Neurology，2006，67：327-329.

29 Kim JM，Jung KH，Sohn CH，et al. Middle cerebral

ar tery plaque and prediction of the infarction

pattern[J]. Arch Neurol，2012，69：1470-1475.

30 Yuan C，Mitsumori LM，Ferguson MS，et al. In

vivo accuracy of multispectral magnetic resonance

4 症状性颅内动脉粥样硬化性狭窄血管内治疗专家共

识组. 症状性颅内动脉粥样硬化性狭窄血管内治疗中

国专家共识[J]. 中华内科杂志，2013，52：271-275.

5 中华医学会神经病学分会，中华医学会神经病学分会

脑血管病学组. 中国缺血性脑卒中和短暂性脑缺血发

作二级预防指南2014[J]. 中华神经科杂志，2015，48：

258-273.

6 中华医学会神经病学分会，中华医学会神经病学分会

神经血管介入协作组，急性缺血性脑卒中介入诊疗指

南撰写组. 中国急性缺血性脑卒中早期血管内介入诊

疗指南[J]. 中华神经科杂志，2015，48：356-361.

7 中华预防医学会卒中预防与控制专业委员会脑血管病

介入学组. 症状性动脉粥样硬化性椎动脉起始部狭窄

血管内治疗中国专家共识[J]. 中华医学杂志，2015，95：

648-653.

8 中华预防医学会卒中预防与控制专业委员会介入学组，

急性缺血性脑卒中血管内治疗中国专家共识组. 急性

缺血性脑卒中血管内治疗中国专家共识[J]. 中华医学

杂志，2014，94：2097-2101.

9 中国卒中学会，中国卒中学会神经介入分会，中华预防

医学会卒中预防与控制专业委员会介入学组. 急性缺

血性卒中血管内治疗中国指南2015[J]. 中国卒中杂志，

2015，10：590-606.

10 中华医学会放射学分会介入学组. 颈动脉狭窄介入治

疗操作规范(专家共识)[J]. 中华放射学杂志，2010，44：

995-998.

11 Bouthillier A，van Loveren HR，Keller JT. Segments

of the internal carotid artery：a new classification[J].

Neurosurgery，1996，38：425-432; discussion 432-433.

12 North American Symptomatic Carotid Endarterectomy

Trial. Methods，patient characteristics，and progress[J].

Stroke，1991，22：711-720.

13 European Carotid Surgery Trialists' Collaborative

Group. MRC European Carotid Surgery Trial：interim

results for symptomatic patients with severe (70-99%)

or with mild (0-29%) carotid stenosis[J]. Lancet，1991，

337：1235-1243.

14 Rothwel l PM，Gi b son R J，Slat t e r y J，e t a l .

Equivalence of measurements of carotid stenosis. A

comparison of three methods on 1001 angiograms.

European Carotid Surgery Trialists' Collaborative

Group[J]. Stroke，1994，25：2435-2439.

15 Wardlaw JM，Lewis SC，Humphrey P，et al. How

does the degree of carotid stenosis affect the accuracy

and interobserver variability of magnetic resonance

angiography?[J]. J Neurol Neurosurg Psychiatry，2001，

71：155-160.

16 Samu e l s OB，Joseph GJ，Lyn n MJ，et a l. A

standardized method for measuring intracranial

arterial stenosis[J]. AJNR Am J Neuroradiol，2000，

21：643-646.

中国卒中杂志 2017年２月 第12卷 第２期 171

imaging for identifying lipid-rich necrotic cores and

intraplaque hemorrhage in advanced human carotid

plaques[J]. Circulation，2001，104：2051-2056.

31 Cai J，Hatsukami TS，Ferguson MS，et al. In vivo

quantitative measurement of intact f ibrous cap

and lipid-rich necrotic core size in atherosclerotic

carotid plaque：comparison of high-resolution，

contrast-enhanced magnetic resonance imaging and

histology[J]. Circulation，2005，112：3437-3444.

32 Ha t s u k ami TS，Ros s R，Pol issa r NL，e t a l .

Visualization of fibrous cap thickness and rupture

in human atherosclerotic carotid plaque in vivo with

high-resolution magnetic resonance imaging[J].

Circulation，2000，102：959-964.

33 Wasserman BA，Smith WI，Trout HH 3rd，et al.

Carotid artery atherosclerosis：in vivo morphologic

characterization with gadolinium-enhanced doubleoblique

MR imaging initial results[J]. Radiology，

2002，223：566-573.

34 Xu WH，Li ML，Gao S，et al. In vivo high-resolution

MR imaging of symptomatic and asymptomatic

middle cerebral artery atherosclerotic stenosis[J].

Atherosclerosis，2010，212：507-511.

35 Xu WH，Li ML，Gao S，et al. Middle cerebral artery

intraplaque hemorrhage：prevalence and clinical

relevance[J]. Ann Neurol，2012，71：195-198.

36 Xu WH，Li ML，Gao S，et al. Plaque distribution

of stenotic middle cerebral artery and its clinical

relevance[J]. Stroke，2011，42：2957-2959.

37 Deg na n AJ，Gal lagher G，Teng Z，et a l. MR

angiography and imaging for the evaluation of middle

cerebral artery atherosclerotic disease[J]. AJNR Am J

Neuroradiol，2012，33：1427-1435.

38 Xu P，Lv L，Li S，et al. Use of high-resolution 3.

0-T magnetic resonance imaging to characterize

atherosclerotic plaques in patients with cerebral

infarction[J]. Exp Ther Med，2015，10：2424-2428.

39 Sui B，Gao P，Lin Y，et al. Distribution and features

of middle cerebral artery atherosclerotic plaques in

symptomatic patients：a 3.0T high-resolution MRI

study[J]. Neurol Res，2015，37：391-396.

40 Molloy ES，Langford CA. Vasculitis mimics[J]. Curr

Opin Rheumatol，2008，20：29-34.

41 Makowski MR，Botnar RM. MR imaging of the

arterial vessel wall：molecular imaging from bench to

bedside[J]. Radiology，2013，269：34-51.

42 Kooi ME，Cappendijk VC，Cleutjens KB，et al.

Accumulation of ultrasmall superparamagnetic

particles of iron oxide in human atherosclerotic

plaques can be detected by in vivo magnetic resonance

imaging[J]. Circulation，2003，107：2453-2458.

43 Trivedi RA，Mallawarachi C，U-King-Im JM，et

al. Identifying inf lamed carotid plaques using in

vivo USPIO-enhanced MR imaging to label plaque

macrophages[J]. Arterioscler Thromb Vasc Biol，2006，

26：1601-1606.

44 Tang TY，Howar th SP，Mi l ler SR，et al. The

ATHEROMA (Atorvastatin Therapy：Effects on

Reduction of Macrophage Activity) Study. Evaluation

using ultrasmall superparamagnetic iron oxideenhanced

magnetic resonance imaging in carotid

disease[J]. J Am Coll Cardiol，2009，53：2039-2050.

45 Tang TY，Patterson AJ，Miller SR，et al. Temporal

dependence of in vivo USPIO-enhanced MRI signal

changes in human carotid atheromatous plaques[J].

Neuroradiology，2009，51：457-465.

46 Pedersen SF，Thrysøe SA，Paaske WP，et al. CMR

assessment of endothelial damage and angiogenesis

in porcine coronary arteries using gadofosveset[J]. J

Cardiovasc Magn Reson，2011，13：10.

47 Lobbes MB，Heeneman S，Passos VL，e t a l .

Gadofosveset-enhanced magnetic resonance imaging

of human carotid atherosclerotic plaques：a proof-ofconcept

study[J]. Invest Radiol，2010，45：275-281.

48 Phinikar idou A，Andia ME，Prot ti A，e t a l .

Noninvasive magnetic resonance imaging evaluation

of endothelial permeability in murine atherosclerosis

using an albumin-binding cont rast agent [J ].

Circulation，2012，126：707-719.

49 Vancraeynest D，Roelants V，Bouzin C，et al. αVβ3

integr in-targeted microSPECT/CT imaging of

inflamed atherosclerotic plaques in mice[J]. EJNMMI

Res，2016，6：29.

50 Schoenhagen P，Ziada KM，Kapadia SR，et al. Extent

and direction of arterial remodeling in stable versus

unstable coronary syndromes：an intravascular

ultrasound study[J]. Circulation，2000，101：598-603.

51 Musialek P，Pieni??ek P，Tracz W，et al. Safety of

embolic protection device-assisted and unprotected

intravascular ultrasound in evaluating carotid artery

atherosclerotic lesions[J]. Med Sci Monit，2012，18：

MT7-18.

52 Hitchner E，Zayed MA，Lee G，et al. Intravascular

ultrasound as a clinical adjunct for carotid plaque

characterization[J]. J Vasc Surg，2014，59：774-780.

53 Diethrich EB，Pauliina Margolis M，Reid DB，et al.

Virtual histology intravascular ultrasound assessment

of carotid artery disease：the Carotid Artery Plaque

Virtual Histology Evaluation (CAPITAL) study[J]. J

Endovasc Ther，2007，14：676-686.

54 Liang Y，Zhu H，Friedman MH. Measurement of

the 3D arterial wall strain tensor using intravascular

172 Chin J Stroke, Feb 2017, Vol 12, No.2

B-mode ultrasound images：a feasibility study[J].

Phys Med Biol，2010，55：6377-6394.

55 Majdouline Y，Ohayon J，Keshavarz-Motamed Z，et

al. Endovascular shear strain elastography for the

detection and characterization of the severity of

atherosclerotic plaques：in vitro validation and in vivo

evaluation[J]. Ultrasound Med Biol，2014，40：890-

903.

56 Roleder T，J?ka?a J，Ka?u?a GL，et al. The basics

of intravascular optical coherence tomography[J].

Postepy Kardiol Interwencyjnej，2015，11：74-83.

57 Regar E，Ligthar t J，Brui n i ng N，et al . The

diagnostic value of intracoronary optical coherence

tomography[J]. Herz，2011，36：417-429.

58 Yoshimu r a S，Kawasaki M，Yamada K，et al.

Visualization of internal carotid artery atherosclerotic

plaques in symptomatic and asymptomatic patients：

a comparison of optical coherence tomography and

intravascular ultrasound[J]. AJNR Am J Neuroradiol，

2012，33：308-313.

59 Yosh imu r a S，Kawasaki M，Hat tor i A，et a l.

Demonstration of intraluminal thrombus in the carotid

artery by optical coherence tomography：technical

case report[J]. Neurosurgery，2010，67：onsE305；

discussion onsE305.

60 Yoshimura S，Kawasaki M，Yamada K，et al. OCT of

human carotid arterial plaques[J]. JACC Cardiovasc

Imaging，2011，4：432-436.

61 Jones MR，Attizzani GF，Given CA 2nd，et al.

Intravascular frequency-domain optical coherence

tomography assessment of carotid artery disease in

symptomatic and asymptomatic patients[J]. JACC

Cardiovasc Interv，2014，7：674-684.

62 Jones MR，Attizzani GF，Given CA 2nd，et al.

Intravascular frequency-domain optical coherence

tomography assessment of atherosclerosis and stentvessel

interactions in human carotid arteries[J]. AJNR

Am J Neuroradiol，2012，33：1494-1501.

63 de Donato G，Setacci F，Sirignano P，et al. Optical

coherence tomography after carotid stenting：rate

of stent malapposition，plaque prolapse and fibrous

cap rupture according to stent design[J]. Eur J Vasc

Endovasc Surg，2013，45：579-587.

64 Setacci C，de Donato G，Setacci F，et al. Safety

and feasibility of intravascular optical coherence

tomography using a nonocclusive technique to

evaluate carotid plaques before and after stent

deployment[J]. J Endovasc Ther，2012，19：303-311.

65 Given CA 2nd，Attizzani GF，Jones MR，et al.

Frequency-domain optical coherence tomography

assessment of human carotid atherosclerosis using

saline f lush for blood clearance without balloon

occlusion[J]. AJNR Am J Neuroradiol，2013，34：

1414-1418.

66 Leng X，Wong LK，Soo Y，et al. Signal intensity ratio

as a novel measure of hemodynamic significance for

intracranial atherosclerosis[J]. Int J Stroke，2013，8：

E46.

67 Liebeskind DS，Kosinski AS，Lynn MJ，et al.

Noninvasive fractional flow on MRA predicts stroke

risk of intracranial stenosis[J]. J Neuroimaging，2015，

25：87-91.

68 Liebe sk i nd DS，Fong AK，Sc a l zo F，e t a l .

SAMMPRIS angiography discloses hemodynamic

effects of intracranial stenosis：computational fluid

dynamics of fractional f low[J]. Stroke，2013，44：

A156.

69 Amin-Hanjani S，Du X，Rose -Fin nel l L，e t

al. Hemody nami c feat ures of symptomat ic

vertebrobasilar disease[J]. Stroke，2015，46：1850-

1856.

70 Amin-Hanjani S，Pandey DK，Rose-Finnell L，et al.

Effect of hemodynamics on stroke risk in symptomatic

atherosclerotic vertebrobasilar occlusive disease[J].

JAMA Neurol，2016，73：178-185.

71 Berger A，Botman KJ，MacCarthy PA，et al. Longterm

clinical outcome after fractional flow reserveguided

percutaneous coronary intervention in patients

with multivessel disease[J]. J Am Coll Cardiol，2005，

46：438-442.

72 Tonino PA，De Bruyne B，Pijls NH，et al. Fractional

f low reserve versus angiography for guiding

percutaneous coronary intervention[J]. N Engl J Med，

2009，360：213-224.

73 De Bruyne B，Pijls NH，Kalesan B，et al. Fractional

flow reserve–guided PCI versus medical therapy in

stable coronary disease[J]. N Engl J Med，2012，367：

991-1001.

74 Miao Z，Liebeskind DS，Lo W，et al. Fractional

f low assessment for the evaluation of intracranial

atherosclerosis：a feasibility study[J]. Interv Neurol，

2016，5：65-75.

75 Liu J，Yan Z，Pu Y，et al. Functional assessment

of cerebral artery stenosis：a pilot study based on

computational fluid dynamics[J]. J Cereb Blood Flow

Metab，2016，pii：0271678X16671321.[Epub ahead of

print]

76 Wang Y，Wang Y，Zhao X，et al. Clopidogrel with

aspirin in acute minor stroke or transient ischemic

attack[J]. N Engl J Med，2013，369：11-19.

77 Wang Y，Pan Y，Zhao X，et al. Clopidogrel with

aspirin in acute minor stroke or transient ischemic

中国卒中杂志 2017年２月 第12卷 第２期 173

attack (CHANCE) trial：one-year outcomes[J].

Circulation，2015，132：40-46.

78 Liu L，Wong KS，Leng X，et al. Dual antiplatelet

therapy in stroke and ICAS：subgroup analysis of

CHANCE[J]. Neurology，2015，85：1154-1162.

79 Wong KS，Chen C，Fu J，et al. Clopidogrel plus

aspirin versus aspirin alone for reducing embolisation

in patients with acute symptomatic cerebral or carotid

artery stenosis (CLAIR study)：a randomised，openlabel，

blinded-endpoint trial[J]. Lancet Neurol，2010，

9：489-497.

80 Chimowitz MI，Lynn MJ，Derdeyn CP，et al. Stenting

versus aggressive medical therapy for intracranial

arterial stenosis[J]. N Engl J Med，2011，365：993-

1003.

81 De rdey n CP，Chimowitz MI，Lynn MJ，et al.

Aggressive medical treatment with or without stenting

in high-risk patients with intracranial artery stenosis

(SAMMPRIS)：the final results of a randomised

trial[J]. Lancet，2014，383：333-341.

82 Chimowitz MI，Lynn MJ，Howlett-Smith H，et al.

Comparison of warfarin and aspirin for symptomatic

intracranial arterial stenosis[J]. N Engl J Med，2005，

352：1305-1316.

83 Markus HS，Droste DW，Kaps M，et al. Dual

antiplatelet therapy with clopidogrel and aspirin in

symptomatic carotid stenosis evaluated using Doppler

embolic signal detection：the Clopidogrel and Aspirin

for Reduction of Emboli in Symptomatic Carotid

Stenosis (CARESS) trial[J]. Circulation，2005，111：

2233-2240.

84 Wang Y，Zhao X，Lin J，et al. Association between

CYP2C19 loss-of-function allele status and efficacy

of clopidogrel for risk reduction among patients with

minor stroke or transient ischemic attack[J]. JAMA，

2016，316：70-78.

85 Huang Y，Cheng Y，Wu J，et al. Cilostazol as an

alternative to aspirin after ischaemic stroke：a

randomised，double-blind，pilot study[J]. Lancet

Neurol，2008，7：494-499.

86 Shinohara Y，Katayama Y，Uchiyama S，et al.

Cilostazol for prevention of secondary stroke (CSPS 2)：

an aspirin-controlled，double-blind，randomised noninferiority

trial[J]. Lancet Neurol，2010，9：959-968.

87 Kwon SU，Cho YJ，Koo JS，et al. Cilostazol prevents

the progression of the symptomatic intracranial

ar terial stenosis：the multicenter double-blind

placebo-controlled trial of cilostazol in symptomatic

intracranial arterial stenosis[J]. Stroke，2005，36：

782-786.

88 Kwon SU，Hong KS，Kang DW，et al. Eff icacy

and safety of combination antiplatelet therapies in

patients with symptomatic intracranial atherosclerotic

stenosis[J]. Stroke，2011，42：2883-2890.

89 Johnston SC，Amarenco P，Albers GW，et al.

Ticagrelor versus aspirin in acute stroke or transient

ischemic attack[J]. N Engl J Med，2016，375：1395.

90 Ke r n a n WN，Ovbiagele B，Black HR，e t a l .

Guidelines for the prevention of stroke in patients

with stroke and transient ischemic attack：a guideline

for healthcare professionals from the American Heart

Association/American Stroke Association[J]. Stroke，

2014，45：2160-2236.

91 Turan TN，Cotsonis G，Lynn MJ，et al. Relationship

between blood pressure and stroke recurrence

in patients with intracranial arterial stenosis[J].

Circulation，2007，115：2969-2975.

92 Yu DD，Pu YH，Pan YS，et al. High blood pressure

increases the risk of poor outcome at discharge and

12-month follow-up in patients with symptomatic

intracranial large artery stenosis and occlusions：

subgroup analysis of the CICAS study[J]. CNS

Neurosci Ther，2015，21：530-535.

93 Powers WJ，Clarke WR，Grubb RL，et al. Lower

stroke risk with lower blood pressure in hemodynamic

cerebral ischemia[J]. Neurology，2014，82：1027-1032.

94 Underhill HR，Yuan C，Zhao XQ，et al. Effect of

rosuvastatin therapy on carotid plaque morphology

and composition in moderately hypercholesterolemic

patients：a high-resolution magnetic resonance

imaging trial[J]. Am Heart J，2008，155：584.e1-e8.

95 Du R，Cai J，Zhao XQ，et al. Early decrease in

carotid plaque lipid content as assessed by magnetic

resonance imaging during treatment of rosuvastatin[J].

BMC Cardiovasc Disord，2014，14：83.

96 Corti R，Fayad ZA，Fuster V，et al. Effects of lipidlowering

by simvastatin on human atherosclerotic

lesions：a longitudinal study by high-resolution，

noninvasive magnet ic resonance imaging[J ].

Circulation，2001，104：249-252.

97 Corti R，Fuster V，Fayad ZA，et al. Lipid lowering

by simvastat in induces regression of human

atherosclerotic lesions：two years' follow-up by highresolution

noninvasive magnetic resonance imaging[J].

Circulation，2002，106：2884-2887.

98 Sibley CT，Vavere AL，Got tlieb I，et al. MRImeasured

regression of carotid atherosclerosis induced

by statins with and without niacin in a randomised

controlled trial：the NIA plaque study[J]. Heart，2013，

99：1675-1680.

99 Lee JM，Robson MD，Yu LM，et al. Effects of highdose

modified-release nicotinic acid on atherosclerosis

174 Chin J Stroke, Feb 2017, Vol 12, No.2

and vascular function：a randomized，placebocontrolled，

magnetic resonance imaging study[J]. J

Am Coll Cardiol，2009，54：1787-1794.

100 Miao Z，Zhang Y，Shuai J，et al. Thirty-day outcome

of a multicenter regist ry study of stenting for

symptomatic intracranial artery stenosis in China[J].

Stroke，2015，46：2822-2829.

101 Thompson JE，Patman RD，Tal k ing ton CM.

Asymptomatic carotid bruit：long term outcome

of patients having endaterectomy compared with

unoperated controls[J]. Ann Surg，1978，188：308-316.

102 Brott TG，Howard G，Roubin GS，et al. Long-term

results of stenting versus endarterectomy for carotidartery

stenosis[J]. N Engl J Med，2016，374：1021-

1031.

（全文完）

专家组名单（按姓氏汉语拼音排序）：

陈会生（沈阳军区总医院）

陈康宁（第三军医大学西南医院）

董强（复旦大学附属华山医院）

高连波（中国医科大学附属第四医院）

何俐（四川大学华西医院）

胡波（华中科技大学同济医学院附属协和医院）

李海峰（山东大学齐鲁医院）

李焰生（上海交通大学医学院附属仁济医院）

刘建林（西安交通大学医学院第一附属医院）

刘丽萍（首都医科大学附属北京天坛医院）

刘新峰（南京军区南京总医院）

楼敏（浙江大学医学院附属第二医院）

罗本燕（浙江大学医学院附属第一医院）

缪中荣（首都医科大学附属北京天坛医院）

汪昕（复旦大学附属中山医院）

王伊龙（首都医科大学附属北京天坛医院）

王拥军（首都医科大学附属北京天坛医院）

武剑（北京清华长庚医院）

徐安定（暨南大学附属第一医院）

徐蔚海（北京协和医院）

许予明（郑州大学第一附属医院）

杨弋（吉林大学白求恩第一医院）

曾进胜（中山大学附属第一医院）

赵锡海（清华大学生物医学影像研究中心）

撰写小组成员：

濮月华（首都医科大学附属北京天坛医院）

荆京（首都医科大学附属北京天坛医院）

宗黎霞（首都医科大学附属北京天坛医院）